Healthcare in the U.S. is marching toward a value-based system, away from the fee-for-service model. Yet low cost, high quality healthcare is an ambitious goal, especially given the divergent objectives in the medical community. How will value-based healthcare be reflected in the pharma, medical and insurance industries?
Healthcare in the U.S. is marching toward a value-based system, away from the fee-for-service model. Yet low cost, high quality healthcare is an ambitious goal, especially given the divergent objectives in the medical community. How will value-based healthcare be reflected in the pharma, medical and insurance industries?
Share this Article
Recommended